Pancreatic Cancer Research

GrantR01CA

Metabolic compartmentalization and the regulation of histone propionylation in cancer

Activity
R01
Institute
CA
Fiscal years
2025–2026
Amount counted
$1,363,619

These are registry fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Abstract public domain (NIH RePORTER)

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDA) is a deadly cancer for which effective treatments are urgently needed. Metabolism is extensively reprogrammed in pancreatic cancer to support tumor growth and progression. The epigenome is sensitive to metabolic alterations since many chromatin modifications depend on and are regulated by the abundance of key intracellular metabolites that are substrates of epigenetic enzymes. Disruption of physiological control of the metabolism-epigenome link in cancer cells has been shown to contribute to tumor growth and progression. Our labs recently identified a novel link between metabolism and the epigenome, though which branched chain amino acid (BCAA) availability and catabolism regulates histone lysine propionylation, a mark associated with transcriptional activation. Although BCAA metabolism is known to be remodeled in PDA, how this impacts chromatin modification and gene expression is unknown. Furthermore, the metabolic route through which BCAA catabolism supplies propionyl-CoA to the nucleus for chromatin modification remains unclear. This project will test the hypothesis that propionyl-CoA, the acyl-donor for histone propionylation, is generated in the nucleus of the cell via a nuclear-localized set of BCAA catabolic enzymes to regulate site-specific histone propionylation and gene expression contributing to tumor growth. We will test this hypothesis in two aims, 1) determine the mechanism of nuclear propionyl-CoA production and 2) Examine the role of BCAA-sensitive histone propionylation in gene regulation and tumor growth. Elucidation of these processes will provide insight into the mechanistic links between BCAA metabolism and PDA tumorigenesis, potentially pointing towards new avenues for therapeutic intervention.

Public health relevance public domain (NIH RePORTER)

PROJECT NARRATIVE Branched chain amino acid (BCAA) metabolism has recently been shown to regulate the chromatin modification histone lysine propionylation, which is associated with transcriptional activation. BCAA metabolism is reprogrammed in pancreatic ductal adenocarcinoma (PDA), a deadly cancer for which effective treatments are urgently needed. This project will examine the mechanisms through which BCAA metabolism regulates histone lysine propionylation and the role of this pathway in gene regulation and PDA tumor growth.